These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28826564)

  • 61. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
    An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S1-8. PubMed ID: 21600525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17).
    Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR
    J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
    Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
    Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality.
    Versmissen J; Botden IP; Huijgen R; Oosterveer DM; Defesche JC; Heil TC; Muntz A; Langendonk JG; Schinkel AF; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2011 Dec; 219(2):690-3. PubMed ID: 21925660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
    Sjouke B; Kusters DM; Kindt I; Besseling J; Defesche JC; Sijbrands EJ; Roeters van Lennep JE; Stalenhoef AF; Wiegman A; de Graaf J; Fouchier SW; Kastelein JJ; Hovingh GK
    Eur Heart J; 2015 Mar; 36(9):560-5. PubMed ID: 24585268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records.
    Iyen B; Qureshi N; Weng S; Roderick P; Kai J; Capps N; Durrington PN; McDowell IF; Soran H; Neil A; Humphries SE
    Atherosclerosis; 2020 Dec; 315():131-137. PubMed ID: 33187671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE.
    Paquette M; Brisson D; Dufour R; Khoury É; Gaudet D; Baass A
    J Clin Lipidol; 2017; 11(5):1161-1167.e3. PubMed ID: 28801029
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands].
    Lansberg PJ; Tuzgöl S; van de Ree MA; Defesche JC; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1437-40. PubMed ID: 10932696
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model.
    Eid WE; Sapp EH; Wendt A; Lumpp A; Miller C
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1078-1090. PubMed ID: 34871430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preliminary spectrum of genetic variants in familial hypercholesterolemia in Argentina.
    Bañares VG; Corral P; Medeiros AM; Araujo MB; Lozada A; Bustamante J; Cerretini R; López G; Bourbon M; Schreier LE
    J Clin Lipidol; 2017; 11(2):524-531. PubMed ID: 28502510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.
    Narverud I; van Lennep JR; Christensen JJ; Versmissen J; Gran JM; Iversen PO; Aukrust P; Halvorsen B; Ueland T; Ulven SM; Ose L; Veierød MB; Sijbrands E; Retterstøl K; Holven KB
    Atherosclerosis; 2015 Nov; 243(1):155-60. PubMed ID: 26386212
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
    Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Bilianou E; Koutagiar I; Agapakis D; Zacharis E; Antza C; Koumaras C; Boutari C; Liamis G; Liberopoulos EN
    Curr Pharm Des; 2021; 27(21):2537-2544. PubMed ID: 33593250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Homozygous familial hypercholesterolemia among French Canadians in Québec Province.
    Moorjani S; Roy M; Gagné C; Davignon J; Brun D; Toussaint M; Lambert M; Campeau L; Blaichman S; Lupien P
    Arteriosclerosis; 1989; 9(2):211-6. PubMed ID: 2923577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.
    Masana L; Zamora A; Plana N; Comas-Cufí M; Garcia-Gil M; Martí-Lluch R; Ponjoan A; Alves-Cabratosa L; Elosua R; Marrugat J; Dégano IR; Ramos R
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31340450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors.
    Jackson CL; Keeton JZ; Eason SJ; Ahmad ZA; Ayers CR; Gore MO; McGuire DK; Sayers MH; Khera A
    JAMA Cardiol; 2019 Jul; 4(7):685-689. PubMed ID: 31116347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.